Novavax NVAX Income Statement (2010-2026)

NASDAQ NVAX
$10.25 -0.09 (-0.87%)
As of: Sep 4, 2026 · 11:50 AM EDT
Reported Financials

Novavax Quarterly Income Statement

Periods 65 quarters
Latest Jun 2026

Novavax reported revenue of $56.70M and net income of -$53.39M for the quarter ended Jun 2026, down 76.3% year over year. This income statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
178.84M222.20M703.97M185.93M734.58M357.40M80.95M424.43M186.99M291.34M93.86M415.48M84.51M88.31M666.65M239.24M70.44M147.14M139.51M56.70M
Cost of RevenueCost of Rev
15.20M271.08M434.59M181.76M34.09M55.78M98.93M154.98M59.21M46.24M60.62M36.67M14.12M15.32M21.50M22.10M30.70M14.25M
Gross Profit
178.84M222.20M688.77M-85.15M299.98M175.63M46.87M368.65M88.06M136.37M34.65M369.24M23.89M51.64M652.54M223.91M48.95M125.03M108.82M42.45M
Operating items
Research & DevelopmentR&D
408.19M962.96M383.48M289.65M304.30M257.85M247.10M219.47M106.23M164.70M92.68M106.95M87.16M104.38M88.94M79.23M98.27M75.88M95.47M70.69M
Selling, General & AdministrativeSG&A
77.79M84.21M95.99M108.16M122.88M161.66M112.53M93.72M107.46M155.24M86.80M101.30M70.75M78.34M48.09M43.61M31.66M34.12M28.78M26.66M
Other Operating ExpensesOther Opex
15.20M271.08M434.59M181.76M34.09M55.78M98.93M154.98M59.21M46.24M60.62M36.67M14.12M15.32M118.53M22.91M30.70M14.25M
Operating ExpensesOpex
485.99M1,047.17M494.68M668.88M861.77M601.28M393.72M368.97M312.62M474.91M238.69M254.49M218.53M219.39M151.14M138.17M248.46M132.91M154.94M111.60M
Operating IncomeOp. Inc
-307.14M-824.97M209.29M-482.96M-127.19M-243.88M-312.77M55.46M-125.63M-183.57M-144.83M161.00M-134.02M-131.08M515.51M101.07M-178.02M14.23M-15.43M-54.91M
EBIT
-307.14M-824.97M209.29M-482.96M-127.19M-243.88M-312.77M55.46M-125.63M-183.57M-144.83M161.00M-134.02M-131.08M515.51M101.07M-178.02M14.23M-15.43M-54.91M
Non-operating items
Non Operating Interest Expenses
5.18M5.14M4.88M6.23M4.17M4.60M4.32M3.12M2.86M4.12M4.11M4.14M4.24M7.58M5.72M5.52M5.48M5.82M4.90M5.69M
Interest & Investment IncomeInt & Inv Inc
0.33M0.30M
Other Non Operating IncomeOther Non Op Inc.
-4.06M0.43M1.65M-19.87M-34.78M63.97M24.36M5.53M-2.98M10.98M3.65M7.73M15.92M13.13M10.06M11.90M-28.71M9.50M11.82M8.92M
Net income details
EBT
-316.39M-829.67M206.07M-509.07M-166.14M-184.51M-292.72M57.87M-131.47M-176.70M-145.29M164.59M-122.33M-73.58M519.85M107.45M-203.04M17.90M-8.51M-51.68M
Tax ProvisionsTaxes
6.04M16.61M2.66M1.42M2.47M-2.26M1.18M-0.14M-0.70M1.69M2.26M2.21M-1.03M7.45M1.20M0.95M-0.66M0.38M0.98M1.71M
Profit After TaxPAT
-322.43M-846.28M203.41M-510.49M-168.61M-182.25M-293.90M58.01M-130.78M-178.39M-147.55M162.38M-121.30M-81.03M518.65M106.51M-202.38M17.50M-9.50M-53.39M
Income from Continuing OperationsIncome (Continuing)
-322.43M-846.28M203.41M-510.49M-168.61M-182.25M-293.90M58.01M-130.78M-178.39M-147.55M162.38M-121.30M-81.03M518.65M106.51M-202.38M17.53M-9.49M-53.39M
Consolidated Net IncomeConsol Net Inc.
-322.43M-846.28M203.41M-510.49M-168.61M-182.25M-293.90M58.01M-130.78M-178.39M-147.55M162.38M-121.30M-81.03M518.65M106.51M-202.38M17.53M-9.49M-53.39M
Income towards Parent CompanyParent Net Inc
-322.43M-846.28M203.41M-510.49M-168.61M-182.25M-293.90M58.01M-130.78M-178.39M-147.55M162.38M-121.30M-81.03M518.65M106.51M-202.38M17.53M-9.49M-53.39M
Net Income towards Common StockholdersNet Income
-322.43M-846.28M203.41M-510.49M-168.61M-182.25M-293.90M58.01M-130.78M-178.39M-147.55M162.38M-121.30M-81.03M518.65M106.51M-202.38M17.53M-9.49M-53.39M
Additional items
EPS (Basic)
-4.31-11.372.66-6.53-2.15-2.33-3.410.65-1.26-1.77-1.051.09-0.76-0.533.220.66-1.250.11-0.06-0.32
EPS (Diluted)
-4.31-11.372.52-6.53-2.15-2.33-3.410.56-1.26-1.77-1.050.98-0.76-0.532.920.60-1.250.10-0.06-0.32
Shares Outstanding
74.75M74.40M76.46M78.14M78.27M78.18M86.16M89.36M103.43M100.77M139.92M148.38M160.05M152.19M161.05M162.02M162.35M161.99M163.28M164.57M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
74.75M74.40M80.71M78.14M78.27M78.18M86.16M104.06M103.43M100.77M139.92M165.85M160.05M152.19M177.62M177.22M162.35M173.10M163.28M164.57M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
75.42M75.84M78.12M78.17M78.48M86.04M86.29M94.31M118.73M100.77M140.37M159.89M160.15M160.42M161.96M162.16M162.47M162.58M164.42M164.82M
EBITDA
-307.14M-824.97M209.29M-482.96M-127.19M-243.88M-312.77M55.46M-125.63M-183.57M-144.83M161.00M-134.02M-131.08M515.51M101.07M-178.02M14.23M-15.43M-54.91M
Interest ExpensesInt Expense
5.18M5.14M4.88M6.23M4.17M4.60M4.32M3.12M2.86M4.12M4.11M4.14M4.24M7.58M5.72M5.52M5.48M5.82M4.90M5.69M
Tax Rate
-1.91%-2.00%1.29%-0.28%-1.49%1.22%-0.40%-0.25%0.53%-0.96%-1.56%1.34%0.84%-10.12%0.23%0.88%0.32%2.10%-11.58%-3.31%